Is DEB-TACE as locoregional therapy before liver transplantation for hepatocellular carcinoma effective?
DEB-TACE can serve as a safe and effective LRT in HCC patients beyond HC before LT, and can improve the prognosis of patients, especially without MAV. The higher Child-Pugh classification and MAV are independent prognostic factors after LT.
Authors
- Liren Lu
- Jianfeng Xu (ORCID: https://orcid.org/0000-0002-1343-8752)
- Liqing Zhang (ORCID: https://orcid.org/0000-0002-3936-4376)
- Zhaodan Ye
Institutions
- Zhejiang Shuren University (CN)
- Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2024-10-03
- DOI
- https://doi.org/10.1186/s12876-024-03434-1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00